Sofinnova Investments’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-598,978
Closed -$29.8M 85
2023
Q4
$29.8M Sell
598,978
-96,397
-14% -$4.71M 1.67% 17
2023
Q3
$37.3M Buy
+695,375
New +$37.1M 2.35% 15
2023
Q1
Sell
-1,965,475
Closed -$95.2M 61
2022
Q4
$95.2M Buy
1,965,475
+700,929
+55% +$30.8M 5.65% 5
2022
Q3
$48.1M Buy
1,264,546
+982,346
+348% +$43.8M 2.8% 8
2022
Q2
$14.1M Buy
+282,200
New +$15M 1.18% 22
2019
Q1
Sell
-327,175
Closed -$14.2M 72
2018
Q4
$14.2M Sell
327,175
-85,571
-21% -$3.77M 1.77% 14
2018
Q3
$18.4M Buy
+412,746
New +$17.6M 1.64% 14

Other funds holding SNY

Sofinnova Investments's SNY Position: Q1 2024 in Review

Sofinnova Investments sold out of Sanofi (SNY) in Q1 2024, closing a stake of 598,978 shares — an estimated $29.8M sold.

Sofinnova Investments first reported a position in SNY in Q3 2018 and held it in 7 quarters. The position peaked at $95.2M in Q4 2022. 711 funds tracked by Wall St. Rank hold SNY as of Q1 2024.

  • Sofinnova Investments reported no remaining Sanofi position as of Q1 2024 after selling out during the quarter.
  • Sofinnova Investments sold 598,978 Sanofi shares in Q1 2024, an estimated $29.8M.
  • Sofinnova Investments first reported a position in Sanofi in Q3 2018 and held it in 7 quarters.
  • Sofinnova Investments's Sanofi position peaked at $95.2M in Q4 2022.
  • 711 funds tracked by Wall St. Rank held Sanofi as of Q1 2024.

Based on Sofinnova Investments's 13F filing for Q1 2024, filed 15 May 2024.